Literature DB >> 11335042

Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia.

S Nudmamud1, G P Reynolds.   

Abstract

Saturable radioligand binding of [(3)H]L-689,560 to the glycine site of the N-methyl-D-aspartate (NMDA) receptor was determined bilaterally in superior temporal cortex (BA22) and prefrontal cortex (BA10) taken post mortem from patients with schizophrenia and matched control subjects. A significant increase in NMDA receptor density above control values was found bilaterally in BA22 in schizophrenia, but not in BA10. The effect was greatest in those patients described as primarily type II, in whom the effect was significantly lateralized, with a greater elevation in the left hemisphere. A significant decrease in NMDA receptor density was found in rat frontal cortex following chronic antipsychotic drug administration, indicating that prior drug treatment was unlikely to have contributed to the differences in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11335042     DOI: 10.1016/s0304-3940(01)01727-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

2.  Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.

Authors:  K A Newell; K Zavitsanou; X-F Huang
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

3.  Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.

Authors:  Chen Zhang; Ming Li
Journal:  Behav Pharmacol       Date:  2012-02       Impact factor: 2.293

4.  NMDA receptor phosphorylation at a site affected in schizophrenia controls synaptic and behavioral plasticity.

Authors:  Bo Li; Nino Devidze; Denis Barengolts; Naseem Prostak; Eleana Sphicas; Alfonso J Apicella; Roberto Malinow; Effat S Emamian
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

Review 5.  The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

Authors:  Peijun Ju; Donghong Cui
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

6.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

7.  Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation.

Authors:  Daniel Martins-de-Souza; Wagner F Gattaz; Andrea Schmitt; José C Novello; Sérgio Marangoni; Christoph W Turck; Emmanuel Dias-Neto
Journal:  BMC Psychiatry       Date:  2009-04-30       Impact factor: 3.630

8.  Altered gene expression in the superior temporal gyrus in schizophrenia.

Authors:  Nikola A Bowden; Rodney J Scott; Paul A Tooney
Journal:  BMC Genomics       Date:  2008-04-29       Impact factor: 3.969

9.  Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia.

Authors:  C S Weickert; S J Fung; V S Catts; P R Schofield; K M Allen; L T Moore; K A Newell; D Pellen; X-F Huang; S V Catts; T W Weickert
Journal:  Mol Psychiatry       Date:  2012-10-16       Impact factor: 15.992

10.  Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia.

Authors:  Vibeke Sørensen Catts; Dominique Suzanne Derminio; Chang-Gyu Hahn; Cynthia Shannon Weickert
Journal:  NPJ Schizophr       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.